Clinical Trials Browser

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

Phase 3 Completed

1,170 enrolled 11 charts

Classical hematology

Venous Thromboembolism

NCT03080883 2025-05-18

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Phase 3 Completed

370 enrolled 16 charts

Other hematologic neoplasm

Neoplasm Metastasis, Pulmonary Embolism, Hematologic Neoplasms, Venous Thrombosis, Intracranial Thrombosis

NCT03692065 2025-02-06

API-CAT

Phase 3 Completed

1,766 enrolled

Neoplasms, Thrombosis

NCT04243122 2024-05-29

AIRPORT-MPN

Phase 2 Completed

44 enrolled

Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT02744092 2023-10-03

CANVAS

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01999179 2022-05-18

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Phase NA Completed

27 enrolled 8 charts

Neoplasms, Venous Thrombosis

NCT04191928 2021-12-23

PAP-UP

Phase 1 Completed

4 enrolled

Gastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism

NCT04192916 2021-02-21

MPN-DOACs

Completed

442 enrolled

Myeloid

Myeloproliferative Disorders

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT02366871 2020-03-31

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Phase 2 Completed

400 enrolled 16 charts

Classical hematology

Venous Thromboembolism

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Phase 4 Completed

50 enrolled 5 charts

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Completed

695 enrolled

Neoplasms, Pulmonary Embolism

NCT02048865 2018-11-20

AVERT

Phase 2 Completed

575 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02581176 2018-06-26

CAP

Phase 4 Completed

300 enrolled

Neoplasms, Venous Thrombosis

NCT03083782 2017-10-11

ACT

Phase 1 Completed

12 enrolled

Classical hematology

Venous Thromboembolism

Clinical Trials

MYELAXAT

CARAVAGGIO

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

API-CAT

AIRPORT-MPN

CANVAS

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

PAP-UP

MPN-DOACs

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

AVERT

CAP

ACT